• Lynx1 Capital Management bought 50,055 Passage Bio common shares at a weighted average USD 4.12.
• Holdings rose to 673,759 shares, held indirectly.
• Weston Nichols was listed as a reporting beneficial owner as a 10% owner.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Passage Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000902664-26-002945), on June 29, 2026, and is solely responsible for the information contained therein.